↑Chen Y, Xu H, Liu J, Zhang C, Leutz A, Mo X(Jul 2007).“The c-Myb functions as a downstream target of PDGF-mediated survival signal in vascular smooth muscle cells”.Biochem Biophys Res Commun360(2): 433–6.doi:10.1016/j.bbrc.2007.06.078.PMID17599807.
↑Klempnauer KH, Symonds G, Evan GI, Bishop JM(June 1984).“Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by chicken c-myb gene”.Cell37(2): 537–47.doi:10.1016/0092-8674(84)90384-2.PMID6327074.
↑Himi E, Mares DJ, Yanagisawa A, Noda K(July 2002).“Effect of grain colour gene (R) on grain dormancy and sensitivity of the embryo to abscisic acid (ABA) in wheat”.J. Exp. Bot.53(374): 1569–74.doi:10.1093/jxb/erf005.PMID12096095.
Oh IH, Reddy EP(1999).“The myb gene family in cell growth, differentiation and apoptosis.”.Oncogene18(19): 3017–33.doi:10.1038/sj.onc.1202839.PMID10378697.
Kalkbrenner F, Guehmann S, Moelling K(1990).“Transcriptional activation by human c-myb and v-myb genes.”.Oncogene5(5): 657–61.PMID2189102.
Westin EH, Gorse KM, Clarke MF(1990).“Alternative splicing of the human c-myb gene.”.Oncogene5(8): 1117–24.PMID2202948.
Dasgupta P, Reddy EP(1990).“Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.”.Oncogene4(12): 1419–23.PMID2687764.
Janssen JW, Vernole P, de Boer PA, Oosterhuis JW, Collard JG(1986).“Sublocalization of c-myb to 6q21----q23 by in situ hybridization and c-myb expression in a human teratocarcinoma with 6q rearrangements.”.Cytogenet. Cell Genet.41(3): 129–35.doi:10.1159/000132217.PMID3007038.
Krieg J, Oelgeschläger M, Janknecht R, Lüscher B(1995).“High affinity DNA binding of native full length c-Myb and differential proteolytic sensitivity of its N- and C-terminal domains.”.Oncogene10(11): 2221–8.PMID7784067.
Jacobs SM, Gorse KM, Westin EH(1994).“Identification of a second promoter in the human c-myb proto-oncogene.”.Oncogene9(1): 227–35.PMID8302584.
Favier D, Gonda TJ(1994).“Detection of proteins that bind to the leucine zipper motif of c-Myb.”.Oncogene9(1): 305–11.PMID8302594.
Glaser R, Lafuse WP, Bonneau RH, Atkinson C, Kiecolt-Glaser JK(1993).“Stress-associated modulation of proto-oncogene expression in human peripheral blood leukocytes.”.Behav. Neurosci.107(3): 525–9.doi:10.1037/0735-7044.107.3.525.PMID8329139.
Dash AB, Orrico FC, Ness SA(1996).“The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb.”.Genes Dev.10(15): 1858–69.doi:10.1101/gad.10.15.1858.PMID8756344.
Vorbrueggen G, Lovrić J, Moelling K(1997).“Functional analysis of phosphorylation at serine 532 of human c-Myb by MAP kinase.”.Biol. Chem.377(11): 721–30.doi:10.1515/bchm3.1996.377.11.721.PMID8960373.
Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, Dash AB, Eisenman RN, Ness SA(1998).“Pim-1 kinase and p100 cooperate to enhance c-Myb activity.”.Mol. Cell2(4): 417–25.doi:10.1016/S1097-2765(00)80141-0.PMID9809063.
Thompson MA, Rosenthal MA, Ellis SL, Friend AJ, Zorbas MI, Whitehead RH, Ramsay RG(1998).“c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.”.Cancer Res.58(22): 5168–75.PMID9823328.
Verbeek W, Gombart AF, Chumakov AM, Müller C, Friedman AD, Koeffler HP(1999).“C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.”.Blood93(10): 3327–37.doi:10.1182/blood.V93.10.3327.PMID10233885.